对OPAT持续输液的证据,抗菌稳定性和可行性考虑的审查
Amy L Van Abel1, Lindsey M Childs-Kean2, Kelsey L Jensen3
1Department of Pharmacy, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Therapeutic advances in infectious disease
|August 28, 2023
概括
使用连续输液 (CI) 的门诊亲肠道抗菌疗法 (OPAT) 提供了诸如节省成本和减少感染等好处. 本综述涵盖了OPAT中CI的临床证据和实践方面.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 门诊亲肠道抗菌疗法 (OPAT) 是一项长期以来的实践,提供了显著的临床和经济优势.
- 在OPAT中,不断发展的治疗策略和药物输送技术带来了持续的挑战和机遇.
- 扩展和持续输注 (CI) 抗微生物药物的使用越来越多,以提高治疗结果.
研究的目的:
- 审查支持使用连续输液 (CI) 在门诊亲肠道抗菌药物治疗 (OPAT) 的临床证据.
- 讨论在OPAT环境中实施CI的实际考虑.
- 评估CI疗程的患者偏好,成本效益和抗微生物稳定性等因素.
主要方法:
- 临床研究的文献综述持续输液 (CI) 在门诊亲肠道抗菌药物治疗 (OPAT) 中.
- 与CI剂量策略相关的药理动力学和药理动力学数据的分析.
- 检查实际实施因素,包括药物稳定性和以患者为中心的护理.
主要成果:
- 在OPAT中,持续输液 (CI) 策略可以优化各种抗微生物药物的药理动力学/药理动力学目标.
- 弹性体器件越来越多地用于在OPAT中提供CI,从而提高了患者的便利性.
- 证据支持CI在OPAT内的特定临床场景中的有效性.
结论:
- 持续输液 (CI) 是优化门诊 (OPAT) 抗菌药物治疗的一个有价值的策略.
- 成功实施需要仔细考虑临床证据,药物特性和患者特定因素.
- 进一步的研究可能会完善最佳的CI协议,并扩大其在OPAT中的应用.
相关概念视频
One-Compartment Open Model for IV Bolus Administration: General Considerations
240
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
240
Antimicrobial Effectiveness
44
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
44
Two-Compartment Open Model: IV Infusion
271
A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
271
One-Compartment Model: IV Infusion
225
Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
225
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
330
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
330


